Glucose monitoring in acute care: Technologies on the horizon

Journal of Diabetes Science and Technology

Volumn 2, Issue 2, 2008, Pages 178-181

  Torjman, Marc C ^a   Dalal, Niti ^a   Goldberg, Michael E ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Acute care; Continuous glucose monitoring; Diabetes technology; Intensive insulin therapy

Indexed keywords

EID: 77956137668     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200202     Document Type: Conference Paper

References (46)

1. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004;99(2):319-24.
2. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia.. Anesth Analg. 1999;89(5):1091-5.
3. Torjman MC, Goldberg ME, Hirsh RA, Littman J. Thinking like a pancreas: a look ahead at diabetes technology in the perioperative setting. Anesth Analg. 2007;105(2):545.
4. Martinez E, Williams K, Pronovost P. Thinking like a pancreas: perioperative glycemic control. Anesth Analg. 2007;104(1):4-6.
5. Joseph JI, Torjman MC. The Artificial Pancreas Symposium: glucose monitoring, insulin delivery, feedback control. Diabetes Technol Ther. 1999;1(3):323-8.
6. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231-9.
7. Corstjens AM, Ligtenberg JJ, Van Der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients.. Crit Care. 2006;10:R135.
8. De Block C, Manuel Y, Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29(8):1750-6.
9. Samuelsson A, Steinvall I, Sjoberg F. Microdialysis shows metabolic effects in skin during fuid resuscitation in burn-injured patients. Crit Care. 2006;10(6):R172.
10. Klonoff DC. Subcutaneous continuous glucose monitoring in severe burn patients. Crit Care Med. 2007;35(5):1445; author reply 1445-6.
11. Davidson PC, Steed RD, Bode BW. Glucommander: a computerdirected intravenous insulin system shown to be safe, simple, and effective in 120, 618 h of operation.. Diabetes Care. 2005;28(10):2418-23.
12. Button E, Keaton P. Glycemic control after coronary bypass graft: using intravenous insulin regulated by a computerized system.. Critical Care Nurs Clin North Am. 2006;18(2):257-65, xi.
13. Coss-Bu JA, Jefferson LS, Stone-McCord S, Ou CN, Watrin C, Sachdeva R, Copeland KC. Evaluation of a real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract. 1999;44(3):175-81.
14. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106(1):160-3.
15. Torjman MC, Goldberg ME, Marr AT, Maldonado M, Littman JJ. Evaluation of an automated blood glucose monitor in cardiac surgery and critically ill ICU patients.. 2007; ASA Abstract 1127.
16. Krinsley J, Zheng P, Hall D, Magarian P. ICU validation of the Optiscanner, a continuous glucose monitoring device. Crit Care Med. 2006;34(12):A67.
17. Center for Disease Control. MMWR, recommendations and reports. 2002;51: No. RR-10.
18. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes. 1990;39(12):1519-26.
19. Vaidya R, Wilkins E. Use of charged membranes to control interference by body chemicals in a glucose biosensor. Med Eng Phys. 1994;16(5):416-21.
20. Eisele S, Ammon HP, Kindervater R, Grobe A, Gopel W. Optimized biosensor for whole blood measurements using a new cellulose based membrane. Biosens Bioelectron. 1994;9(2):119-24.
21. Nishida K, Sakakida M, Ichinose K, Uemura T, Uehara M, Kajiwara K, Miyata T, Shichiri M, Ishihara K, Nakabayashi N. Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate.. Med Prog Technol. 1995;21(2):91-103.
22. Yang S, Atanasov P, Wilkins E. A glucose biosensor based on an oxygen electrode: in-vitro performances in model buffer solution and in blood plasma.. Biomed Instrum Technol. 1996;30(1):55-61.
23. Joseph JI, Torjman MC. (2004) Implantable glucose sensors. In: Wnek G, Bowlin GL, editors. Encyclopedia of biomaterials and biomedical engineering. New York: Marcel-Dekker; 2004. p. 683-92.
24. Verbrugge L, Crisis D, Van Dijk J, Higgin M, Van Wezel H. Accuracy of a prototype central venous continuous amperometric glucose sensor following CABG. Anesthesiology. 2007;107:A1427.
25. Gerard SO, Neary V, Apuzzo D, Giles ME, Krinsley J. Implementing an intensive glucose management initiative: strategies for success. Crit Care Nurs Clin North Am. 2006;18(4):531-43.
26. Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006;34(12):2974-8.
27. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56(2):125-44.
28. Hovorka R, Kremen J, Blaha J, Matias M, Anderlova K, Bosanska L, Roubicek T, Wilinska ME, Chassin LJ, Svacina S, Haluzik M. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial.. J Clin Endocrinol Metab. 2007;92(8):2960-4.
29. Ligtenberg JJ, Meertens JH, Monteban-Kooistra WE, Tulleken JE, Zijlstra JG. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients.. Diabetes Care. 2006;29(8):1987.
30. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients: Response to Ligtenberg et al.. Diabetes Care. 2006;29(8):1987-8.
31. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature.. Crit Care. 2006;10(1):R19.
32. Ligtenberg JJ, Stemerdink A, Vogelzang M, Borggreve HF, Herngreen T, Zijlstra JG. Tight glucose control and hypoglycemia: should we bother? Crit Care Med. 2007;35(4):1218.
33. Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas.. Diabetes Technol Ther. 2005;7(1):28-47.
34. Wintergerst KA, Deiss D, Buckingham B, Cantwell M, Kache S, Agarwal S, Wilson DM, Steil G. Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. Diabetes Technol Ther. 2007;9(3):211-22.
35. Van Herpe T, Espinoza M, Pluymers B, Goethals I, Wouters P, Van Den Berghe G, De Moor B. An adaptive input-output modeling approach for predicting the glycemia of critically ill patients. Physiol Meas. 2006;27(11):1057-69.
36. Kadish AH. Automation control of blood sugar: a servomechanism for glucose monitoring and control. Am J Med Electron. 1964;3:82-6.
37. Clemens AH, Chang PH, Myers RW. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS). Horm Metab Res. 1977;Suppl. 7:23-33.
38. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Met. 2006;23(1):1-12.
39. Vanhorebeek I, Langouche L, Van Den Berghe G. Tight blood glucose control: what is the evidence? Crit Care Med. 2007;35(9 Suppl):S496-502.
40. Van Den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcome? Ann Intern Med. 2007;146(4):307-8.
41. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.. Ann Intern Med. 2007;146(4):233-43.
42. Malhotra A. Intensive insulin in intensive care. N Engl J Med. 2006;354(5):516-8.
43. Clement S. Better glycemic control in the hospital: beneficial and feasible. Cleve Clin J Med. 2007;74(2):111-20.
44. Klonoff DC. Business and economics of diabetes. J Diabetes Sci Technol. 2008;2(1):1-3.
45. Zijlstra JG, Corstjens AM, Tulleken JE, Meertens JH, Ligtenberg JJ. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;130(6):1953-4.
46. Van Den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients.. Crit Care Med. 2006;34(3):612-6.